At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02171 CARSGEN-B
Trading 12-05 15:17:56
18.290
+0.030
+0.16%
High18.500Low17.900Vol980.00K
Open18.290D1 Closing18.260Amplitude3.29%
Mkt Cap10.50BTradable Cap10.50BTotal Shares574.00M
T/O17.88MT/O Rate0.17%Tradable Shares574.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled
Stock News  ·  12-03 19:38
10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled
CARSGEN-B (02171) Repurchased 173,500 Shares for Approximately HK$2.963 Million on December 1
Stock News  ·  12-01
CARSGEN-B (02171) Repurchased 173,500 Shares for Approximately HK$2.963 Million on December 1
CARsgen Therapeutics Files HKEX Disclosure on Issuance of [number] New Shares at [price] Each
Reuters  ·  12-01
CARsgen Therapeutics Files HKEX Disclosure on Issuance of [number] New Shares at [price] Each
Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 30,000 Shares at HK$16.39 per Share
Stock News  ·  11-25
Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 30,000 Shares at HK$16.39 per Share
CARSGEN-B (02171) Repurchases 360,000 Shares for HK$5.9567 Million on November 24
Stock News  ·  11-24
CARSGEN-B (02171) Repurchases 360,000 Shares for HK$5.9567 Million on November 24
CARsgen Therapeutics Files Next Day Disclosure to HKEX for Issue of [X] New Shares at [HK$X.XX] Each
Reuters  ·  11-24
CARsgen Therapeutics Files Next Day Disclosure to HKEX for Issue of [X] New Shares at [HK$X.XX] Each
CARsgen Therapeutics (02171) Announces Next Day Disclosure Return and Share Repurchase Details
Bulletin Express  ·  11-21
CARsgen Therapeutics (02171) Announces Next Day Disclosure Return and Share Repurchase Details
CARsgen (02171) Reports Share Repurchase Activity and Treasury Share Update
Bulletin Express  ·  11-20
CARsgen (02171) Reports Share Repurchase Activity and Treasury Share Update
CARSGEN-B (02171) Repurchases 168,000 Shares for HK$2.97 Million on November 20
Stock News  ·  11-20
CARSGEN-B (02171) Repurchases 168,000 Shares for HK$2.97 Million on November 20
Hong Kong Stock Buyback Report | November 18
Stock News  ·  11-18
Hong Kong Stock Buyback Report | November 18
Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast
Stock News  ·  11-18
Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast
CARSGEN-B (02171) Repurchased 112,000 Shares for HK$1.968 Million on November 17
Stock News  ·  11-17
CARSGEN-B (02171) Repurchased 112,000 Shares for HK$1.968 Million on November 17
CARsgen Therapeutics (SEHK:2171) Is Up 13.3% After Encouraging CAR-T Cell Therapy Results in Tough Cases
Simply Wall St.  ·  11-16
CARsgen Therapeutics (SEHK:2171) Is Up 13.3% After Encouraging CAR-T Cell Therapy Results in Tough Cases
CARsgen Therapeutics' Substantial Shareholder Boosts Shareholding
MT Newswires Live  ·  11-14
CARsgen Therapeutics' Substantial Shareholder Boosts Shareholding
CARsgen (2171) Announces Updated Share Repurchase Plan and Substantial Shareholder’s Increased Holdings
Bulletin Express  ·  11-13
CARsgen (2171) Announces Updated Share Repurchase Plan and Substantial Shareholder’s Increased Holdings
CARSGEN-B (02171) Plans to Repurchase Up to Approximately 25.46 Million Shares; Major Shareholder Increases Holdings by 100,000 Shares
Stock News  ·  11-13
CARSGEN-B (02171) Plans to Repurchase Up to Approximately 25.46 Million Shares; Major Shareholder Increases Holdings by 100,000 Shares
Hong Kong Stock Buyback Summary | November 12
Stock News  ·  11-12
Hong Kong Stock Buyback Summary | November 12
CARSGEN-B (02171) Repurchases 245,000 Shares for HK$4.047 Million on November 11
Stock News  ·  11-11
CARSGEN-B (02171) Repurchases 245,000 Shares for HK$4.047 Million on November 11
Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 30,000 Shares at HK$16.4 per Share
Stock News  ·  11-11
Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 30,000 Shares at HK$16.4 per Share
A Fresh Look at CARsgen Therapeutics (SEHK:2171) Valuation After New CAR-T Trial Data Release
Simply Wall St.  ·  11-10
A Fresh Look at CARsgen Therapeutics (SEHK:2171) Valuation After New CAR-T Trial Data Release

Introduction

Company Name.
CARSGEN-B
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
CARsgen Therapeutics Holdings Ltd is an investment holding company primarily engaged in discovering, researching and developing cell therapies. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The Company conducts its business in the domestic and overseas markets.
Issue price:
--